Biomedix Incubator (Israel) Performance
| BMDX Stock | ILS 19,200 480.00 2.56% |
On a scale of 0 to 100, Biomedix Incubator holds a performance score of 5. The firm shows a Beta (market volatility) of 0.38, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Biomedix Incubator's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biomedix Incubator is expected to be smaller as well. Please check Biomedix Incubator's total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether Biomedix Incubator's price patterns will revert.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Biomedix Incubator are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Biomedix Incubator sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Fifty Two Week Low | 1,792.00 | |
| Fifty Two Week High | 1,866.00 |
Biomedix |
Biomedix Incubator Relative Risk vs. Return Landscape
If you would invest 1,718,000 in Biomedix Incubator on August 25, 2024 and sell it today you would earn a total of 202,000 from holding Biomedix Incubator or generate 11.76% return on investment over 90 days. Biomedix Incubator is generating 0.3416% of daily returns and assumes 4.614% volatility on return distribution over the 90 days horizon. Simply put, 41% of stocks are less volatile than Biomedix, and 94% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Biomedix Incubator Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biomedix Incubator's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biomedix Incubator, and traders can use it to determine the average amount a Biomedix Incubator's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.074
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BMDX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.61 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.34 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Biomedix Incubator is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biomedix Incubator by adding it to a well-diversified portfolio.
Biomedix Incubator Fundamentals Growth
Biomedix Stock prices reflect investors' perceptions of the future prospects and financial health of Biomedix Incubator, and Biomedix Incubator fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biomedix Stock performance.
| Return On Equity | -21.76 | |||
| Return On Asset | -14.0 | |||
| Current Valuation | 14.72 M | |||
| Shares Outstanding | 2.07 M | |||
| Price To Earning | (545.45) X | |||
| Price To Book | 361.86 X | |||
| Revenue | 2 K | |||
| EBITDA | (1.46 M) | |||
| Cash And Equivalents | 5.71 M | |||
| Cash Per Share | 5.10 X | |||
| Book Value Per Share | 4.98 X | |||
| Cash Flow From Operations | (1.62 M) | |||
| Earnings Per Share | (1.10) X | |||
| Total Asset | 9 M | |||
| Retained Earnings | (181 M) | |||
| Current Asset | 9 M | |||
About Biomedix Incubator Performance
By analyzing Biomedix Incubator's fundamental ratios, stakeholders can gain valuable insights into Biomedix Incubator's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biomedix Incubator has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biomedix Incubator has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Biomedix Incubator Ltd is a venture capital firm and accelerator specializing in start-up and incubation investments. Biomedix Incubator Ltd. was founded in 2000 and is based in Ramat Gan, Israel with an additional office in New York, New York. Biomedix Incubator is traded on Tel Aviv Stock Exchange in Israel.Things to note about Biomedix Incubator performance evaluation
Checking the ongoing alerts about Biomedix Incubator for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biomedix Incubator help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biomedix Incubator had very high historical volatility over the last 90 days | |
| The company reported the revenue of 2 K. Net Loss for the year was (1.36 M) with loss before overhead, payroll, taxes, and interest of (39 K). | |
| Biomedix Incubator has accumulated about 5.71 M in cash with (1.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.1. |
- Analyzing Biomedix Incubator's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biomedix Incubator's stock is overvalued or undervalued compared to its peers.
- Examining Biomedix Incubator's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biomedix Incubator's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biomedix Incubator's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biomedix Incubator's stock. These opinions can provide insight into Biomedix Incubator's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Biomedix Stock analysis
When running Biomedix Incubator's price analysis, check to measure Biomedix Incubator's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomedix Incubator is operating at the current time. Most of Biomedix Incubator's value examination focuses on studying past and present price action to predict the probability of Biomedix Incubator's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomedix Incubator's price. Additionally, you may evaluate how the addition of Biomedix Incubator to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |